Filter
438
Filtered Results: 438
Text search:
Revised
National
TB
Control
Programme,
India
Featured
Recommendations
46
New Publications
164
Language
Document type
No document type
312
Guidelines
44
Studies & Reports
43
Manuals
19
Strategic & Response Plan
10
Situation Updates
5
Training Material
4
Resource Platforms
1
Countries / Regions
India
106
Nepal
23
Myanmar / Burma
17
Global
11
South Africa
9
Bangladesh
9
Nigeria
8
South–East Asia Region
8
Malawi
7
Uganda
6
Indonesia
5
Sierra Leone
4
Kenya
4
Western and Central Europe
4
Asia
4
Pakistan
3
Mozambique
3
Africa
3
Congo, Democratic Republic of
2
Ethiopia
2
Zimbabwe
2
Philippines
2
Zambia
2
Tanzania
2
Cambodia
2
Thailand
2
Botswana
2
Sri Lanka
2
East and Southern Africa
2
Latin America and the Carribbean
2
Bhutan
2
Timor Leste/ East Timor
2
Guinea
1
Liberia
1
Senegal
1
Afghanistan
1
Syria
1
Rwanda
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Namibia
1
Lesotho
1
Yemen
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Eastern Europe
1
North Korea
1
Laos
1
Russia
1
Vietnam
1
North America
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
189
Clinical Guidelines
56
Women & Child Health
19
Public Health
17
Key Resources
6
Pharmacy & Technologies
6
Capacity Building
4
Toolboxes
TB
93
HIV
61
AMR
16
Global Health Education
11
COVID-19
10
Caregiver
10
Disability
8
Refugee
7
NTDs
7
Polio
6
Mental Health
6
Ebola
4
Rapid Response
4
Health Financing Toolbox
4
Planetary Health
3
Pharmacy
3
Conflict
2
Natural Hazards
2
Cholera
1
Specific Hazards
1
NCDs
1
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
he global architecture for providing development assistance for health (DAH)
has become increasing complex in the last decade, with many new funding agencies entering the health sector.
This study presents a detailed picture of European Union (EU) and EU member state originating DAH
between 2006 ...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
Using Epidemiology to Support Primary Health Care. Updated version of the WHO handbook published in the early 1990's entitled: Manual of Epidemiology for District Health Management or those with an interest in applied epidemiology in primary health care and district health systems
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
Background book on Management of the Child with a Serious Infection or Severe Malnutrition
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Guidelines
June 2017
HIV strategic information for impact
Integrated Management of pregnancy and childbirth
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
Economic Issues, Policies and Option for Action
